The Hand Surgery Landscape| Volume 48, ISSUE 3, P292-300, March 2023

Download started.


Medical Cannabis in Hand Surgery: A Review of the Current Evidence

Published:January 04, 2023DOI:
      Acute and chronic pain management remains an ongoing challenge for hand surgeons. This has been compounded by the ongoing opioid epidemic in the United States. With the increasing legalization of medical and recreational cannabis throughout the United States and other countries, previous societal stigmas about this substance keep evolving, and recognition of medical cannabis as an opioid-sparing pain management alternative is growing. A review of the current literature demonstrates a strong interest from patients regarding the use of medical cannabis for pain control. Current evidence demonstrates its efficacy and safety for chronic musculoskeletal and neuropathic pain. However, definitive conclusions regarding the efficacy of cannabis for pain control in hand and upper extremity conditions require continued investigation. The purpose of this article is to provide a general review of the mechanism of medical cannabis and a scoping review of the current evidence for its efficacy, safety, and potential applicability in hand and upper extremity conditions.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Florence C.S.
        • Zhou C.
        • Luo F.
        • Xu L.
        The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013.
        Med Care. 2016; 54: 901-906
        • Gomes T.
        • Tadrous M.
        • Mamdani M.M.
        • Paterson J.M.
        • Juurlink D.N.
        The burden of opioid-related mortality in the United States.
        JAMA Netw Open. 2018; 1: e180217
      1. National Institute on Drug Abuse, Opioid Overdose Crisis. Accessed June 5, 2022.

        • National Conference of State Legislatures
        State medical marijuana laws.
        • Daniller A.
        Two-thirds of Americans support marijuana legalization.
        • Heng M.
        • McTague M.F.
        • Lucas R.C.
        • Harris M.B.
        • Vrahas M.S.
        • Weaver M.J.
        Patient perceptions of the use of medical marijuana in the treatment of pain after musculoskeletal trauma: a survey of patients at 2 trauma centers in Massachusetts.
        J Orthop Trauma. 2018; 32: e25-e30
      2. Leroux TS. Understanding the rate and perceived efficacy of cannabis use for the management of chronic musculoskeletal pain. American Academy of Orthopaedic Surgeons; March 26, 2020.

        • Khelemsky Y.
        • Goldberg A.T.
        • Hurd Y.L.
        • et al.
        Perioperative patient beliefs regarding potential effectiveness of marijuana (cannabinoids) for treatment of pain: a prospective population survey.
        Reg Anesth Pain Med. 2017; 42: 652-659
        • Abrams D.I.
        • Jay C.A.
        • Shade S.B.
        • et al.
        Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.
        Neurology. 2007; 68: 515-521
        • Corey-Bloom J.
        • Wolfson T.
        • Gamst A.
        • et al.
        Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
        CMAJ. 2012; 184: 1143-1150
        • Ellis R.J.
        • Toperoff W.
        • Vaida F.
        • et al.
        Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
        Neuropsychopharmacology. 2009; 34: 672-680
        • Ware M.A.
        • Wang T.
        • Shapiro S.
        • et al.
        Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.
        CMAJ. 2010; 182: E694-E701
        • Whiting P.F.
        • Wolff R.F.
        • Deshpande S.
        • et al.
        Cannabinoids for medical use: a systematic review and meta-analysis.
        JAMA. 2015; 313: 2456-2473
        • Wilsey B.
        • Marcotte T.
        • Deutsch R.
        • Gouaux B.
        • Sakai S.
        • Donaghe H.
        Low-dose vaporized cannabis significantly improves neuropathic pain.
        J Pain. 2013; 14: 136-148
        • Evanoff A.B.
        • Quan T.
        • Dufault C.
        • Awad M.
        • Bierut L.J.
        Physicians-in-training are not prepared to prescribe medical marijuana.
        Drug Alcohol Depend. 2017; 180: 151-155
        • Zou S.
        • Kumar U.
        Cannabinoid Receptors and the Endocannabinoid system: signaling and function in the central nervous system.
        Int J Mol Sci. 2018; 19
        • Kilaru A.
        • Chapman K.D.
        The endocannabinoid system.
        Essays Biochem. 2020; 64: 485-499
        • Johal H.
        • Vannabouathong C.
        • Chang Y.
        • Zhu M.
        • Bhandari M.
        Medical cannabis for orthopedic patients with chronic musculoskeletal pain: does evidence support its use?.
        Ther Adv Musculoskelet Dis. 2020; 12 (1759720x20937968)
        • MacCallum C.A.
        • Russo E.B.
        Practical considerations in medical cannabis administration and dosing.
        Eur J Intern Med. 2018; 49: 12-19
        • Nagarkatti P.
        • Pandey R.
        • Rieder S.A.
        • Hegde V.L.
        • Nagarkatti M.
        Cannabinoids as novel anti-inflammatory drugs.
        Future Med Chem. 2009; 1: 1333-1349
        • Kleeman-Forsthuber L.T.
        • Dennis D.A.
        • Jennings J.M.
        Medicinal cannabis in orthopedic practice.
        J Am Acad Orthop Surg. 2020; 28: 268-277
        • Solowij N.
        • Broyd S.
        • Greenwood L.M.
        • et al.
        A randomized controlled trial of vaporized Δ(9)-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
        Eur Arch Psychiatry Clin Neurosci. 2019; 269: 17-35
        • Pomahacova B.
        • Van der Kooy F.
        • Verpoorte R.
        Cannabis smoke condensate III: the cannabinoid content of vaporized Cannabis sativa.
        Inhal Toxicol. 2009; 21: 1108-1112
        • Huestis M.A.
        Human cannabinoid pharmacokinetics.
        Chem Biodivers. 2007; 4: 1770-1804
        • Ko G.D.
        • Bober S.L.
        • Mindra S.
        • Moreau J.M.
        Medical cannabis - the Canadian perspective.
        J Pain Res. 2016; 9: 735-744
        • US Food and Drug Administration
        FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD).
        • Wang T.
        • Collet J.P.
        • Shapiro S.
        • Ware M.A.
        Adverse effects of medical cannabinoids: a systematic review.
        CMAJ. 2008; 178: 1669-1678
        • Ware M.A.
        • Wang T.
        • Shapiro S.
        • Collet J.P.
        COMPASS study team. Cannabis for the management of pain: assessment of safety study (COMPASS).
        J Pain. 2015; 16: 1233-1242
        • Buck J.S.
        • Bloomer A.K.
        • Wally M.K.
        • Seymour R.B.
        • Hsu J.R.
        The current evidence for marijuana as medical treatment.
        J Bone Joint Surg Am. 2020; 102: 2096-2105
        • Asbridge M.
        • Hayden J.A.
        • Cartwright J.L.
        Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis.
        BMJ. 2012; 344: e536
        • Johal H.
        • Devji T.
        • Chang Y.
        • Simone J.
        • Vannabouathong C.
        • Bhandari M.
        Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis.
        Clin Med Insights Arthritis Musculoskelet Disord. 2020; 13 (1179544120906461)
        • Degenhardt L.
        • Hall W.
        • Lynskey M.
        Testing hypotheses about the relationship between cannabis use and psychosis.
        Drug Alcohol Depend. 2003; 71: 37-48
        • Anthony J.C.
        The epidemiology of cannabis dependence.
        in: Stephens R.S. Roffman R. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge University Press, Cambridge2006: 58-105
        • Jouanjus E.
        • Lapeyre-Mestre M.
        • Micallef J.
        French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications∗. Cannabis use: signal of increasing risk of serious cardiovascular disorders.
        J Am Heart Assoc. 2014; 3 (e000638)
        • Fones L.
        • Townsend C.
        • Hoyen H.
        • et al.
        Hand surgery patient perspectives on medical cannabis: a survey of over 600 patients.
        J Hand Surg Glob Online. 2023; 5: 102-107
        • Madden K.
        • George A.
        • van der Hoek N.J.
        • Borim F.M.
        • Mammen G.
        • Bhandari M.
        Cannabis for pain in orthopedics: a systematic review focusing on study methodology.
        Can J Surg. 2019; 62: 369-380
        • McDougall J.J.
        • Muley M.M.
        • Philpott H.T.
        • Reid A.
        • Krustev E.
        Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor decreases end-stage osteoarthritis pain and peripheral neuropathy in mice.
        Arthritis Res Ther. 2017; 19: 106
        • Sophocleous A.
        • Börjesson A.E.
        • Salter D.M.
        • Ralston S.H.
        The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice.
        Osteoarthritis Cartilage. 2015; 23: 1586-1594
        • Philpott H.T.
        • O’Brien M.
        • McDougall J.J.
        Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.
        Pain. 2017; 158: 2442-2451
        • Verrico C.D.
        • Wesson S.
        • Konduri V.
        • et al.
        A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.
        Pain. 2020; 161: 2191-2202
        • O’Brien M.
        • McDougall J.J.
        Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
        Curr Opin Pharmacol. 2018; 40: 104-109
        • Fader L.
        • Scharf Z.
        • DeGeorge Jr., B.R.
        Assessment of medical cannabis in patients with osteoarthritis of the thumb basal joint.
        J Hand Surg Am. 2021; (S0363–5023(21)00691-2)
        • Piper B.J.
        • Beals M.L.
        • Abess A.T.
        • et al.
        Chronic pain patients’ perspectives of medical cannabis.
        Pain. 2017; 158: 1373-1379
        • Vela J.
        • Dreyer L.
        • Petersen K.K.
        • Arendt-Nielsen L.
        • Duch K.S.
        • Kristensen S.
        Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.
        Pain. 2022; 163: 1206-1214
        • Huggins J.P.
        • Smart T.S.
        • Langman S.
        • Taylor L.
        • Young T.
        An efficient randomized, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee.
        Pain. 2012; 153: 1837-1846
        • Stauch C.M.
        • Ammerman B.
        • Sepulveda D.
        • et al.
        Biomechanical effects of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), the major constituents of cannabis, in a Sprague Dawley rat Achilles tendon surgical repair model: a pilot study.
        Am J Sports Med. 2021; 49: 2522-2527
        • Fitzcharles M.A.
        • Ste-Marie P.A.
        • Häuser W.
        • et al.
        Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials.
        Arthritis Care Res (Hoboken). 2016; 68: 681-688
        • Nowell W.B.
        • Gavigan K.
        • Silverman S.L.
        Cannabis for rheumatic disease pain: a review of current literature.
        Curr Rheumatol Rep. 2022; 24: 119-131
        • Blake D.R.
        • Robson P.
        • Ho M.
        • Jubb R.W.
        • McCabe C.S.
        Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
        Rheumatology (Oxford). 2006; 45: 50-52
        • Richards B.L.
        • Whittle S.L.
        • Buchbinder R.
        Neuromodulators for pain management in rheumatoid arthritis.
        Cochrane Database Syst Rev. 2012; 1CD008921
        • Labrum J.T. I.V.
        • Ilyas A.M.
        The opioid epidemic: postoperative pain management strategies in orthopedics.
        JBJS Rev. 2017; 5: e14
        • Gazendam A.
        • Nucci N.
        • Gouveia K.
        • Abdel Khalik H.
        • Rubinger L.
        • Johal H.
        Cannabinoids in the management of acute pain: a systematic review and meta-analysis.
        Cannabis Cannabinoid Res. 2020; 5: 290-297
        • Stevens A.J.
        • Higgins M.D.
        A systematic review of the analgesic efficacy of cannabinoid medications in the management of acute pain.
        Acta Anaesthesiol Scand. 2017; 61: 268-280
        • Holdcroft A.
        • Maze M.
        • Doré C.
        • Tebbs S.
        • Thompson S.
        A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management.
        Anesthesiology. 2006; 104: 1040-1046
        • Bebee B.
        • Taylor D.M.
        • Bourke E.
        • et al.
        The CANBACK trial: a randomized, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain.
        Med J Aust. 2021; 214: 370-375
        • Echeverria-Villalobos M.
        • Todeschini A.B.
        • Stoicea N.
        • Fiorda-Diaz J.
        • Weaver T.
        • Bergese S.D.
        Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations.
        J Clin Anesth. 2019; 57: 41-49
        • Hill K.P.
        Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review.
        JAMA. 2015; 313: 2474-2483
        • Wilsey B.
        • Marcotte T.
        • Tsodikov A.
        • et al.
        A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.
        J Pain. 2008; 9: 506-521
        • Banerjee S.
        • McCormack S.
        CADTH Rapid response reports.
        in: Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines. Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada2019
        • Nielsen S.
        • Sabioni P.
        • Trigo J.M.
        • et al.
        Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis.
        Neuropsychopharmacology. 2017; 42: 1752-1765
        • Cooper Z.D.
        • Bedi G.
        • Ramesh D.
        • Balter R.
        • Comer S.D.
        • Haney M.
        Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
        Neuropsychopharmacology. 2018; 43: 2046-2055
        • Bhashyam A.R.
        • Heng M.
        • Harris M.B.
        • Vrahas M.S.
        • Weaver M.J.
        Self-reported marijuana use is associated with increased use of prescription opioids following traumatic musculoskeletal injury.
        J Bone Joint Surg Am. 2018; 100: 2095-2102
        • Reiman A.
        • Welty M.
        • Solomon P.
        Cannabis as a substitute for opioid-based pain medication: patient self-report.
        Cannabis Cannabinoid Res. 2017; 2: 160-166
        • Renslo B.
        • Greis A.
        • Liu C.S.
        • Radakrishnan A.
        • Ilyas A.M.
        Medical cannabis use reduces opioid prescriptions in patients with osteoarthritis.
        Cureus. 2022; 14: e21564
        • Greis A.
        • Larsen E.
        • Liu C.
        • Renslo B.
        • Radakrishnan A.
        • Wilson-Poe A.R.
        Perceived efficacy, reduced prescription drug use, and minimal side effects of cannabis in patients with chronic orthopedic pain.
        Cannabis Cannabinoid Res. 2021; (10.1089/can.2021.0088)
        • Greis A.
        • Renslo B.
        • Wilson-Poe A.R.
        • Liu C.
        • Radakrishnan A.
        • Ilyas A.M.
        Medical cannabis use reduces opioid prescriptions in patients with chronic back pain.
        Cureus. 2022; 14: e21452
        • Bradford A.C.
        • Bradford W.D.
        • Abraham A.
        • Bagwell Adams G.
        Association between us state medical cannabis laws and opioid prescribing in the Medicare part d population.
        JAMA Intern Med. 2018; 178: 667-672
        • Shi Y.
        Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever.
        Drug Alcohol Depend. 2017; 173: 144-150
        • Wen H.
        • Hockenberry J.M.
        Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees.
        JAMA Intern Med. 2018; 178: 673-679
        • Chaudhry H.J.
        • Hengerer A.S.
        • Snyder G.B.
        Medical board expectations for physicians recommending marijuana.
        JAMA. 2016; 316: 577-578